EZZ Life Science Holdings Limited

EZZ

AU0000130569

Food Processing

Delayed Australian S.E. Other stock markets 01:50:03 19/06/25 pm AEST			5-day change	1st Jan Change
2.270 ^AUD	+10.73%		+30.84%	-26.06%

11:47am	EZZ Life Science Launches in the US; Shares Up 10%	MT
08:26am	Ezz Life Science Launches In U.S. Market And Receives FDA Registrations	RE

EZZ Life Science Signs Multi-Year Distribution Agreement With Rofa Enterprises

Published on 10/06/2025 at 11:38

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about EZZ Life Science Holdings Limited

EZZ Life Science Launches in the US; Shares Up 10%	11:47am	MT
Ezz Life Science Launches In U.S. Market And Receives FDA Registrations	08:26am	RE
EZZ Life Science Holdings Signs Distribution Agreement with ROFA for Thailand, Vietnam, Singapore; Shares Jump 9%	10/06	MT
EZZ Life Science Signs Multi-Year Distribution Agreement With Rofa Enterprises	10/06	RE
Ezz Life Science Determines Fully Franked Interim Dividend Of A$0.020 Per Share	06/05	RE
EZZ Life Science Holdings Limited(ASX:EZZ) added to S&P/ASX Emerging Companies Index	24/03	CI
EZZ Signs US Manufacturing Deal for Nutritional Supplements; Shares Fall 6%	11/03	MT
EZZ Life Science Announces Manufacturing Agreement With GLSP Inc.	11/03	RE
EZZ Life Science Holdings Limited Provides Sales Guidance for the Fiscal Second Half of 2025	26/02	CI
EZZ Life Science Holdings Limited, H1 2025 Earnings Call, Feb 26, 2025	26/02
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2024	26/02	CI
EZZ Life Science Holdings Limited Announces Change of Company Secretary	03/02	CI
EZZ Life Science Holdings to Join MSCI World Micro Cap Index	12/11	MT
EZZ Life Science Holdings Logs Over AU$15 Million in Fiscal Q1 Customer Receipts; Shares Rise 3%	24/10/24	MT
EZZ Life Science Holdings Limited Announces Change of Address	23/09/24	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2024	28/08/24	CI
EZZ Life Science Launches New Functional Food Products	06/08/24	MT
EZZ Life Science Sees AU$19 Million in Cash by End of Q4	27/06/24	MT
EZZ Life Science Expanding to US Market After FDA Approval of Food Supplement Products; Shares Hit All-Time High	25/06/24	MT
EZZ Life Science Signs Five-Year Sales Agreement with Pinehills; Shares Climb 6%	31/05/24	MT
EZZ Life's Receipts from Customers Up 111% in Fiscal Q3	26/04/24	MT
EZZ Life Science Completes AU$854,000 Placement with Kingstone Venture Capital	12/04/24	MT
Renewed Rate Cut Hopes Lift Australian Shares	27/03/24	MT
Ezz Life Science Posts 43% H1 Revenue Increase to AU$21.7 Million, EBITDA Falls 7% to AU$1.7 Million	27/03/24	MT
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02/24	CI

Chart EZZ Life Science Holdings Limited

Duration

Period

EZZ: Dynamic Chart

EZZ Life Science Holdings Limited is an Australian genomic life science company. The Company has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), children's health, and weight management. The Company's segments include Brought in Lines and Company Owned products. Its portfolio includes EZZ and EAORON. The EZZ-branded product range encompasses a broad selection of health and wellbeing products, catering to individuals across all age groups and owned by the Company. The EAORON-branded products comprise a range of facial care items, and the Company serves as the exclusive distributor in Australia and New Zealand for selected channels. The EZZ-branded products include EZZ Hair Growth Spray Duo, EZZ Multi Vitamins Milk Powder for Children (for children ages three plus), EZZ KidzSure Formulated Nutrition Powder (for children ages three plus) and EZZ VitalSure Formulated Nutrition Powder (for adults).

Employees

Sector

Food Processing

Calendar

27/08 - Q4 2025 Earnings Release (Projected)

More about the company